Alyssa Krasinskas – 29 October 2007

Shigeru Marubashi, Keizo Dono, Hiroaki Nagano, Tadafumi Asaoka, Naoki Hama, Shogo Kobayashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Morito Monden – 29 October 2007 – Little information is available on the characteristics and clinical significance of serum bilirubin level early after liver transplantation. The aim of this study was to clarify the risk factors for early graft loss and to assess the significance of postoperative hyperbilirubinemia as a predictor of graft outcome in living donor liver transplantation (LDLT).

Silvana Zanlungo, Juan Francisco Miquel, Flavio Nervi – 29 October 2007

Mark D. Gorrell – 29 October 2007

Giovanni L. Ricci, Maria Teresa Melgosa, Felip Burgos, José Luis Valera, Sandra Pizarro, Josep Roca, Roberto Rodriguez‐Roisin, Joan Albert Barberà – 29 October 2007 – The role of acute pulmonary vasodilator testing in portopulmonary hypertension (PoPH), a current contraindication for orthotopic liver transplantation (OLT), has not been thoroughly elucidated.

Manjushree Gautam, Kapil B. Chopra, David D. Douglas, Rebecca A. Stewart, Shimon Kusne – 29 October 2007 – Bacterial infections are a serious complication of end‐stage liver disease (ESLD) that occurs in 20% to 60% of patients. We retrospectively reviewed medical records of patients with ESLD who were identified by our microbiology laboratory as having Streptococcus salivarius bacteremia. Of 592 patients listed for transplantation between January 1998 and January 2006, 9 (1.5%) had 10 episodes of S salivarius bacteremia.

Josep M. Llovet – 29 October 2007

Kayvan Roayaie, Sandy Feng – 29 October 2007 – Currently, liver transplantation is the optimal cure for hepatocellular cancer (HCC) limited to the liver.

James F. Trotter, Karen A. Wisniewski, Norah A. Terrault, James E. Everhart, Milan Kinkhabwala, Robert M. Weinrieb, Jeffrey H. Fair, Robert A. Fisher, Alan J. Koffron, Sammy Saab, Robert M. Merion, A2ALL Study Group – 29 October 2007 – The purpose of donor evaluation for adult‐to‐adult living donor liver transplantation (LDLT) is to discover medical conditions that could increase the donor postoperative risk of complications and to determine whether the donor can yield a suitable graft for the recipient.

Alex Rovira, Beatriz Mínguez, F. Xavier Aymerich, Carlos Jacas, Elena Huerga, Juan Córdoba, Juli Alonso – 29 October 2007 – Focal T2‐weighted white matter lesions (WML) on brain magnetic resonance imaging (MRI), mimicking those seen in cerebrovascular small‐vessel disease described in patients with persistent hepatic encephalopathy, decreased in volume with the improvement of hepatic encephalopathy. This outcome has been interpreted as a decrease in the edema that it is proposed to be involved in the pathogenesis of hepatic encephalopathy.